After Hours
$
11.11
Change
0.00 0.00%
Volume
Volume 4,749
Aug 12, 2022, 4:01 p.m.
Quotes are delayed by 20 min
Previous close
$ 11.09
$ 11.11
Change
+0.02 +0.18%
Day low
Day high
$11.02
$11.44

52 week low
52 week high
$7.00
$21.50

Market cap
$378.54M
Average volume
173,414
P/E ratio
N/A
Rev. per Employee
$337,089
EPS
-2.26
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on EYPT
-
EyePoint Pharmaceuticals downgraded to neutral from buy at B. Riley FBR
- Tomi Kilgore
-
EyePoint Pharmaceuticals stock price target cut to $4.00 from $5.75 at B. Riley FBR
- Tomi Kilgore
-
EyePoint Pharma shares jump on FDA approval of Yutiq implant
- Ciara Linnane
-
EyePoint Pharma shares surge 8% premarket as FDA approves Yutiq for uveitis
- Ciara Linnane
-
- Barron's Online
-
PSivida's stock soars 41% in active premarket trade after positive trial results
- Tomi Kilgore
-
PSivida started at outperform with $6 stock price target at FBR & Co.
- Tomi Kilgore
-
FDA OKs pSivida uveitis drug for Phase III trials
- MarketWatch.com
-
Monday’s biggest gaining and declining stocks
- Kate Gibson
-
Alimera, pSivida slammed by FDA move
- Val Brickates Kennedy
-
Alimera, pSivida crushed by FDA setback
- Val Brickates Kennedy
-
Alimera, pSivida, Bayer lead drug-stock rally
- Val Brickates Kennedy
-
Javelin rockets as drug stocks head south
- Val Brickates Kennedy
-
Forest Labs falls, pSivida rallies
- Val Brickates Kennedy
-
Stocks in the Spotlight Wednesday
- Barron's Online
-
Drug stocks sluggish; Achillion, pSivida rally
- Val Brickates Kennedy
Analyst Ratings
-
- Benzinga.com
-
- Benzinga.com
Other News on EYPT
-
10-Q: EYEPOINT PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Notable earnings before Wednesday's open
- Seeking Alpha
-
EyePoint reports preliminary Q2 net product revenue $11.3M
- Seeking Alpha
-
10-Q: EYEPOINT PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
- Loading more headlines...
Earnings Announcement
Press Releases on EYPT
-
EyePoint Pharmaceuticals to Host Investor Day on July 18, 2022
- GlobeNewswire
-
EyePoint Throws in lot with OcuMension
- Baystreet.ca
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com